Evidence map›Paper›PMID 42331751›Full record

ArticleNucleic acids research2026

ZEB1 drives terminal erythroid maturation by controlling the GATA2-KLF1 regulatory switch.

Alexia Kinoo, Virginie Deleuze, Mohammad Salma, Noémie Legoff, Jérémie Candotti, Pedro Gonzalez-Menendez, Axel Joly, Jérémy Galtier, Julie Charmeaux-Goulot, Sanjay Chahar and 14 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Alexia KinooIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0009-0008-7206-5942
Virginie DeleuzeIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0000-0001-9872-1946
Mohammad SalmaIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-3648-1809
Noémie LegoffIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0009-0007-6828-1768
Jérémie CandottiIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0009-0001-3362-1482
Pedro Gonzalez-MenendezIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0000-0003-3114-6304
Axel JolyIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0009-0003-6365-3412
Jérémy GaltierIGMM, Univ Montpellier, CNRS, Montpellier, France.
Julie Charmeaux-GoulotIGMM, Univ Montpellier, CNRS, Montpellier, France.
Sanjay ChaharIGMM, Univ Montpellier, CNRS, Montpellier, France.
Peggy RaynaudCRBM, University of Montpellier, CNRS, Montpellier, France.ORCID 0000-0003-1224-8495
Haoyang ZhengIGMM, Univ Montpellier, CNRS, Montpellier, France.
Betty RouaisnelIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-5377-4187
Quentin BouvierIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0009-0003-3049-5526
Céline FauxCRBM, University of Montpellier, CNRS, Montpellier, France.
Frédérique VerdierInitiatives IdEx Globule Rouge d'Excellence (InIdex GR-Ex), Université Paris Cité, Paris, France.ORCID 0000-0001-7267-0298
Dominique HelmlingerCRBM, University of Montpellier, CNRS, Montpellier, France.ORCID 0000-0003-1501-0423
Sara El HossInitiatives IdEx Globule Rouge d'Excellence (InIdex GR-Ex), Université Paris Cité, Paris, France.ORCID 0000-0003-1711-2829
Thiago Trovati MacielInitiatives IdEx Globule Rouge d'Excellence (InIdex GR-Ex), Université Paris Cité, Paris, France.ORCID 0000-0002-9347-981X
Naomi TaylorIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-2459-4558
Olivier HermineInitiatives IdEx Globule Rouge d'Excellence (InIdex GR-Ex), Université Paris Cité, Paris, France.ORCID 0000-0003-2574-3874
Sandrina KinetIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0000-0003-0699-108X
Charlotte Andrieu-SolerIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-3287-6117
Eric SolerIGMM, Univ Montpellier, CNRS, Montpellier, France.ORCID 0000-0003-0521-7463

Funding

CNRSFondation pour la Recherche Médicale FRM DEQ20180339221French National Research Agency ANR-11-IDEX-0005-02French National Research Agency ANR-PRC-ZEBERYFrench Society of Hematology-SFHIdex Université Paris Cité ANR-18-IDEX-0001_GR-ExIGMMLaboratory of Excellence GR-Ex ANR-11-LABX-0051MontpellierSIRIC Montpellier Cancer INCa-DGOS-INSERM-ITMO Cancer_18004
6 · The paper itself

Abstract

Erythropoiesis is a highly coordinated process governed by lineage-defining transcription factors. While several master regulators have been characterized, many additional factors expressed in erythroid progenitors remain poorly understood. Here, we identify the epithelial-to-mesenchymal transition (EMT)-associated transcription factor ZEB1 as a previously unrecognized regulator of erythroid maturation. ZEB1 is expressed in murine and human erythroid progenitors, and its loss impairs proliferation and disrupts the erythroid transcriptional network. Mechanistically, ZEB1 interacts with KLF1 and governs both its expression dynamics and nuclear localization. In ZEB1-deficient cells, GATA2 silencing is delayed due to failure of KLF1 to properly accumulate in the nucleus, impairing KLF1-mediated repression of GATA2 and perturbing the GATA2-KLF1 regulatory switch that drives late-stage erythropoiesis. Consistent with these findings, ZEB1 downregulation hampers maturation of primary human CD34⁺-derived erythroid cells. Together, our findings establish KLF1 as a repressor of GATA2, and ZEB1 as a critical enforcer of erythroid transcriptional circuitry, and demonstrate that erythroid cells recruit EMT-associated factors to ensure lineage completion.

Indexed as

Erythroid Precursor CellsErythropoiesisGATA2 Transcription FactorKruppel-Like Transcription FactorsZinc Finger E-box-Binding Homeobox 1AnimalsCell LineEpithelial-Mesenchymal TransitionGene Expression RegulationGene Knockout TechniquesHumansMiceerythroid Kruppel-like factorGATA2 protein, humanGata2 protein, mouseGATA2 Transcription FactorKruppel-Like Transcription FactorsZEB1 protein, humanZEB1 protein, mouseZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID42331751
PMCPMC13286653

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.